ME02355B - Derivati 2-0ks0-1-pirolidinil imidazotiadiazola - Google Patents

Derivati 2-0ks0-1-pirolidinil imidazotiadiazola

Info

Publication number
ME02355B
ME02355B MEP-2016-44A MEP4416A ME02355B ME 02355 B ME02355 B ME 02355B ME P4416 A MEP4416 A ME P4416A ME 02355 B ME02355 B ME 02355B
Authority
ME
Montenegro
Prior art keywords
methyl
imidazo
thiadiazol
pyrrolidin
trifluoromethyl
Prior art date
Application number
MEP-2016-44A
Other languages
German (de)
English (en)
French (fr)
Unknown language (me)
Inventor
Yannick Quesnel
Laurent Turet
Joël Mercier
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42034570&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME02355(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of ME02355B publication Critical patent/ME02355B/me

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MEP-2016-44A 2009-10-23 2010-10-21 Derivati 2-0ks0-1-pirolidinil imidazotiadiazola ME02355B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09173912 2009-10-23
EP10781818.9A EP2491045B1 (en) 2009-10-23 2010-10-21 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
PCT/EP2010/006434 WO2011047860A1 (en) 2009-10-23 2010-10-21 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives

Publications (1)

Publication Number Publication Date
ME02355B true ME02355B (me) 2016-06-20

Family

ID=42034570

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2016-44A ME02355B (me) 2009-10-23 2010-10-21 Derivati 2-0ks0-1-pirolidinil imidazotiadiazola

Country Status (30)

Country Link
US (1) US8822508B2 (OSRAM)
EP (1) EP2491045B1 (OSRAM)
JP (1) JP5808020B2 (OSRAM)
KR (1) KR20120102058A (OSRAM)
CN (1) CN102574869A (OSRAM)
AR (1) AR078722A1 (OSRAM)
AU (1) AU2010310100B2 (OSRAM)
BR (1) BR112012009310B8 (OSRAM)
CA (1) CA2778194C (OSRAM)
CL (1) CL2012001031A1 (OSRAM)
CY (1) CY1117288T1 (OSRAM)
DK (1) DK2491045T3 (OSRAM)
EA (1) EA201200616A1 (OSRAM)
ES (1) ES2565515T3 (OSRAM)
HR (1) HRP20160263T1 (OSRAM)
HU (1) HUE028668T2 (OSRAM)
IL (1) IL218696A0 (OSRAM)
IN (1) IN2012DN02793A (OSRAM)
MA (1) MA33679B1 (OSRAM)
ME (1) ME02355B (OSRAM)
MX (1) MX347070B (OSRAM)
PE (1) PE20121562A1 (OSRAM)
PH (1) PH12012500570A1 (OSRAM)
PL (1) PL2491045T3 (OSRAM)
RS (1) RS54595B1 (OSRAM)
SI (1) SI2491045T1 (OSRAM)
SM (1) SMT201600076B (OSRAM)
TN (1) TN2012000147A1 (OSRAM)
TW (1) TW201118103A (OSRAM)
WO (1) WO2011047860A1 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2559288T3 (es) * 2011-04-18 2016-02-11 Ucb Biopharma Sprl Derivados de 2-oxo-1-imidazolidinil imidazotiadiazol
US9581654B2 (en) 2013-02-12 2017-02-28 Johnson Controls Technology Company Vehicle battery monitoring system
MX373715B (es) 2014-01-21 2020-05-08 Janssen Pharmaceutica Nv Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso.
HRP20191646T1 (hr) 2014-01-21 2019-12-13 Janssen Pharmaceutica Nv Kombinacije koje sadržavaju pozitivne alosteričke modulatore ili ortosteričke agoniste metabotropnog glutamatergičnog receptora podtip 2 i njihova uporaba
TW201908324A (zh) * 2017-07-10 2019-03-01 比利時商優稀美生物醫藥公司 2-側氧-1-咪唑啶基咪唑噻二唑衍生物
ES2896331T3 (es) 2017-07-10 2022-02-24 UCB Biopharma SRL Derivados del 2-oxo-1,3-oxazolidinilimidazotiadiazol
CN107827870B (zh) * 2017-10-24 2019-11-08 江苏仁明生物科技有限公司 一种正电子药物[18f]fpmmp及其制备方法与中间体
CA3083166A1 (en) 2017-12-12 2019-06-20 UCB Biopharma SRL 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
ES2947618T3 (es) * 2018-05-08 2023-08-14 UCB Biopharma SRL Derivados de 1-imidazotiadiazolo-2H-pirrol-5-ona
CN113549052B (zh) * 2021-07-09 2022-09-02 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 4-苯基-1-(吡啶-4-基甲基)吡咯烷-2-酮衍生物及其制备方法和应用
WO2025132331A1 (en) 2023-12-21 2025-06-26 UCB Biopharma SRL Compounds for treatment of a hyperkinetic movement disorder
CN119606962B (zh) * 2025-02-17 2025-05-02 中国人民解放军总医院第三医学中心 padsevonil在制备治疗TFE3重排性肾细胞癌的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412357D0 (en) 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412358D0 (en) 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
JP2007513105A (ja) * 2003-12-02 2007-05-24 ユ セ ベ ソシエテ アノニム イミダゾール誘導体、その製法及び使用
EP2308867A3 (en) * 2005-06-01 2011-10-19 UCB Pharma S.A. 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses

Also Published As

Publication number Publication date
CN102574869A (zh) 2012-07-11
KR20120102058A (ko) 2012-09-17
PE20121562A1 (es) 2012-11-30
JP2013508321A (ja) 2013-03-07
SMT201600076B (it) 2016-04-29
AU2010310100A1 (en) 2012-05-17
WO2011047860A1 (en) 2011-04-28
TW201118103A (en) 2011-06-01
AU2010310100B2 (en) 2015-09-10
RS54595B1 (en) 2016-08-31
MA33679B1 (fr) 2012-10-01
US8822508B2 (en) 2014-09-02
PH12012500570A1 (en) 2012-10-22
AR078722A1 (es) 2011-11-30
HUE028668T2 (en) 2016-12-28
HRP20160263T1 (hr) 2016-04-08
JP5808020B2 (ja) 2015-11-10
MX347070B (es) 2017-04-11
CA2778194A1 (en) 2011-04-28
CL2012001031A1 (es) 2012-09-14
EP2491045A1 (en) 2012-08-29
MX2012003839A (es) 2012-05-08
ES2565515T3 (es) 2016-04-05
IL218696A0 (en) 2012-05-31
BR112012009310B1 (pt) 2021-01-12
BR112012009310A2 (pt) 2016-06-07
SI2491045T1 (sl) 2016-04-29
CA2778194C (en) 2016-07-12
IN2012DN02793A (OSRAM) 2015-07-24
TN2012000147A1 (en) 2013-09-19
EA201200616A1 (ru) 2012-12-28
DK2491045T3 (en) 2016-03-14
EP2491045B1 (en) 2015-12-23
BR112012009310B8 (pt) 2021-05-25
PL2491045T3 (pl) 2016-06-30
CY1117288T1 (el) 2017-04-26
US20120245208A1 (en) 2012-09-27

Similar Documents

Publication Publication Date Title
ME02355B (me) Derivati 2-0ks0-1-pirolidinil imidazotiadiazola
JP7575518B2 (ja) Nav1.8阻害剤としての2-オキソイミダゾリジン-4-カルボキサミド
HRP20171999T1 (hr) Novi derivati aminopirimidina
KR102001745B1 (ko) 키나제 억제제로서 유용한 인돌 카르복스아미드 화합물
JP6524081B2 (ja) ジヒドロピリミジン化合物及び医薬におけるその適用
PE20090493A1 (es) DERIVADOS DE LA 6-CICLOAMINO-3-(PIRIDAZIN-4-IL)IMIDAZO[1,2-b]-PIRIDAZINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
HRP20151250T1 (hr) Derivati izoksazolo-piridina
JP2014525432A5 (OSRAM)
JP6636539B2 (ja) 変形性関節症の治療のためのadamts阻害剤としての5−[(ピペラジン−1−イル)−3−オキソ−プロピル]−イミダゾリジン−2,4−ジオン誘導体
ME02394B (me) Pirazolohinolinski derivati kao inhibitori pde9
HRP20151419T1 (hr) Derivati 2-okso-1-imidazolidinil imidazotiadiazola
JP2008513516A5 (OSRAM)
JP2017512789A (ja) ジヒドロピリミジン化合物及び医薬におけるその適用
ME02409B (me) Novi heterociklični derivati i njihova upotreba u tretmanu neuroloških poremećaja
NZ592238A (en) Pharmaceutical compositions comprising 4-isopropyl-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridine derivatives
HRP20160002T1 (hr) Bicikliäśki heterocikliäśki spojevi kao inhibitori protein tirozin kinaze
RU2010117156A (ru) Гетероциклические соединения в качестве антагонистов crth2 рецептора
ZA200600424B (en) Bicyclic imidazol derivatives against flaviviridae
CN101534824A (zh) 作为化学活素受体拮抗剂的氨基吡咯烷
HRP20110458T1 (hr) Inhibitori rna-ovisne rna-polimeraze iz virusa hepatitisa c, te pripravci i liječenje u kojem se koriste
WO2012122011A2 (en) Amino-quinolines as kinase inhibitors
JP2016506962A5 (OSRAM)
RU2006126663A (ru) Полициклические средства для лечения респираторно-синцитиальных вирусных инфекций
JP2008537930A5 (OSRAM)
HRP20100180T1 (hr) Novi spoj piridazina i njegova primjena